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Abstract 
Computer-Aided Detection and Diagnosis (CAD) of medical images has been 
developed and tested for the last three decades. It is designed to be an effective time-
saving assistant and provide doctors with a wealth of diagnostic information in clinical 
practice. Traditional CAD techniques utilize the features of manual extraction of images 
and algorithms that use shallow supervised learning. They have great limitations in 
medical image classification, effective feature extraction, and segmentation. In order to 
overcome these limitations, deep learning has emerged as a promising technology in CAD 
development. In this study, my motivation is to investigate an optimal approach of 
applying Convolutional Neural Network (CNN), one of the deep learning models, to 
assist detection of residual breast cancer using histopathology images after Neoadjuvant 
treatment (NAT). In this process, CNN models were implemented and compared using 
different optimization objectives and evaluation metrics. 
Specifically, the CAD system used two CNN schemes, namely, ResNet and SE-
ResNeXt. To detect the residual cancer cells from the pathology images after NAT, a 
regression CAD system was developed to predict cancer cellularity value followed by 
applying a concordance evaluation metric to compare and verify the effectiveness of the 
model. The performance of integrated models for predicting cancer cellularity and 
providing doctors with second information is almost the same as the performance of the 
supplementary information given by other doctors.  
To distinguish classes of cancer cellularity in the pathology images, a 
classification CAD system was developed to predict the probability of classes. The 
classier performance was evaluated using the Receiver Operating Characteristic (ROC) 
xi 
 
method. When using a 5-fold cross-validation method to classify the classes of pathology 
images, the best area under the ROC curve was 0.905±0.075. The results of study 
indicated that CNN based deep learning is a promising CAD technology, which can 
significantly improve the diagnostic efficacy of detecting residual breast cancer cells in 
pathology images after NAT with high performance. 
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Chapter 1: Introduction 
1.1 Breast cancer and screening using radiographic imaging 
Breast cancer, which refers to a malignant tumor, is an uncontrolled growth of 
breast cells. A tumor can be benign (not dangerous to health) or malignant (has the 
potential to be dangerous). Benign tumors are not considered cancerous. The cells in 
benign tumors are close to normal in appearance. They grow slowly and do not invade 
nearby tissues or spread to other parts of the body. Malignant tumors are cancerous 
because malignant cells can grow rapidly and eventually spread beyond the original 
tumor to other parts of the body [1]. Thus, it is important to detect and treat malignant 
tumors in the early stage. 
Most breast cancers are a type of carcinoma called adenocarcinoma, which starts 
in cells that make up glandular tissue. The most common symptom of breast cancer is a 
new lump or mass. A painless, hard mass that has irregular edges is more likely to be 
cancer, but breast cancers can be tender, soft, or rounded. They can even be painful [2]. 
For women in the United States, breast cancer death rates are higher than those 
for any other cancer, besides lung cancer. About 1 in 8 U.S. women (about 12.4%) will 
develop invasive breast cancer over the course of her lifetime. About 41,760 women in 
the U.S. are expected to die in 2019 from breast cancer, though death rates have been 
decreasing since 1989 [3]. These decreases are thought to be the result of treatment 
advances, earlier detection through screening, and increased awareness. 
Imaging tests using the modalities, such as Mammography, Magnetic Resonance 
Imaging (MRI) and Ultrasound, are clinically accepted in aiming to detect and analyze 
the tumor which is still not visible from the epidermis. However, imaging tests have limits; 
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no imaging test can show a single cancer cell or even a few. Other than this, it is a quite 
difficult task for the certified radiologists in breast imaging to interpret the mammogram 
with high detection sensitivity and specificity. In fact, especially in the breast area, the 
dense fibro-glandular tissues overlapping as well as the large heterogeneity of breast 
lesions will produce different diagnostic results from different radiologists due to the high 
inter-reader variability [4]. Thus, in the breast cancer screening environment, high recall 
rates of radiologists will result in a large number of biopsies to determine whether the 
tumor is malignant or benign based on histopathology test and analysis, which is the best 
and gold-standard method in the clinical practice. 
1.2 Breast cancer diagnosis in pathology  
Pathology has always been regarded as a "bridge discipline" between basic 
medicine and clinical medicine, which fully demonstrates its irreplaceably important role 
in medicine, which is determined by the nature and tasks of pathology. Specifically, 
pathology lays a scientific theoretical foundation for mastering the nature, diagnosis, 
treatment, and prevention of diseases and directly participates in clinical diagnosis and 
treatment. As a field of general inquiry and research, the four major tasks of pathology 
include cause (etiology), mechanisms of development (pathogenesis), structural 
alterations of cells (morphologic changes), and the consequences of changes (clinical 
manifestations) [5]. 
The methods of pathological test are diverse, such as biopsy, blood analysis, 
dissection, and other applications of medical microscopy. When conducting pathological 
diagnosis of breast cancer, the pathologists collect the tissue samples extracted by biopsy, 
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which include the use of different methods of local excision, clamping, needle aspiration, 
and scraping, removal, etc. to acquire samples of the patient’s diseased tissue. 
With the development of natural science, medical science has gradually formed 
many sub-disciplines, and their common purpose and tasks are through studying the life 
activities of normal and diseased organisms from different fields and in different ways, 
to prevent diseases and to protect human health. Therefore, pathology is closely related 
to anatomy, histology, embryology, physiology, biochemistry, parasitology, 
microbiology, etc. in basic medicine.  
1.2.1 Histopathology 
Histological observation is one of the most commonly used means of observing 
and studying diseases. By making the diseased tissue into slices several micrometers thick, 
staining them with different materials, and then observing the microscopic lesions with a 
microscope, the resolution of the naked eye observation is improved hundreds of times, 
and the understanding of diseases and lesions is deepened. The pathologists usually utilize 
histopathology which is combining histological observation and pathology to diagnose 
diseased tissue after biopsy in breast cancer. 
Histopathology contrasts with cytopathological methods which use free cells or 
tissue fragments and aid in the diagnosis of certain infectious diseases. Histopathological 
examination of the tissue begins with surgery, biopsy or autopsy [6]. Once the targeted 
breast tissue region is biopsied, the samples taken are studied manually under the 
microscope by a pathologist. And typically, the tissue is removed from the organism and 
placed in a fixative to stabilize the tissue to prevent decay. 
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In the entire field of diagnostic histopathology, the role of pathologists in tumor 
diagnosis is unparalleled. Unfortunately, patients or non-professionals know nothing 
about this and often take it for granted that their diagnostician is a surgeon, clinician or 
oncologist. In fact, for any patient with swelling or mass, a histopathological report is the 
primary factor in diagnosing, predicting clinical progression, and determining treatment. 
However, many patients are reluctant to carry out the histopathology test because to take 
biopsy is an invasive examination. Therefore, histopathology is often performed after the 
image test and surgery. 
Breast histopathology can be used not only to detect the benign and malignant 
tumors after surgery, but can also be used to diagnosis the stage of breast cancer, follow 
up chemotherapy or radiation therapy to prevent cell proliferation, and identify whether 
cancer cells have been completely eliminated. 
1.2.2 Neoadjuvant treatment and cancer cellularity 
Neoadjuvant treatment (NAT) of breast cancer is an option for patients with 
locally advanced disease. In addition to the treatment’s effect on tumor size, NAT may 
alter the cancer cellularity. Tumor response to the therapy provides useful information 
for patient management and can guide decisions about subsequent therapy. Tumor size 
may not decrease, but the overall cellularity may be markedly reduced, making residual 
cancer cellularity an important factor in assessing response.  
Cellularity within the tumor bed is defined as the percentage area of the overall 
tumor bed that is comprised of tumor cells (invasive or in situ). The histopathological 
examination of the tissue sections after surgery to estimate the residual tumor and the 
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assessment of cellularity is an important component of tumor burden assessment. It’s a 
very helpful feedback for NAT of breast cancer. 
In the current clinical practice, cancer cellularity is manually estimated by 
pathologists on haematoxylin and eosin (H&E) stained slides, the quality and reliability 
of which might be impaired by inter-observer variability which potentially affects 
prognostic power assessment in NAT trials [7, 8]. Although this procedure is also 
qualitative and time-consuming in the current practice, cellularity fraction of cancer is a 
better prognostic indicator to illustrate the therapy results without segmenting the bound 
of the cancer cell or indexing the cell’s characteristic individually [9]. 
1.3 Digital pathology 
Whenever using optical microscopes or electron microscopes, pathologists who 
diagnose pathology images need to operate microscopes manually. The data size of 
pathology images is huge when compared to radiology images, in order to save time costs, 
pathologists often use their experience to determine suspected areas for diagnosis and 
observation, rather than for the whole image. Therefore, reading such a big size of images 
by pathologists is a tedious and high error rate job. However, with the rapid development 
of the information age in these decades, the emergence of digital pathology can 
effectively revolute this situation. Digital pathology images are obtained through medical 
instruments, such as Aperio Digital Pathology Slide Scanner, a commercialized available 
whole slide scanner to produce digital images, which can display whole digital slides in 
computer monitors in less than 60 seconds. It also can change the magnification manually 
in computers which is the same as observing the glass slide under a conventional 
microscope. 
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Meanwhile, relatively objective diagnostic reports often need to be diagnosed by 
more than one pathologist. Because different pathologists often have different diagnosis 
results, we call it inter-reader variability. If two pathologists are not in the same laboratory, 
it is difficult for them to give a diagnosis of the pathological image under a conventional 
microscope at the same time. Along with the development of digital pathology, images 
can be transmitted in the network without being constrained by space. Also, digital 
pathology can assist telemedicine (or tele-pathology) to diagnosis jointly and even to 
better serve remote areas without or with few highly experienced pathologists. 
Digital pathology is a disruptive technology, as technology becomes more cost-
effective, digital pathology is becoming more common. Digital pathology will 
undoubtedly allow pathologists to make more accurate and consistent diagnoses in the 
near future. 
1.4. Computer-aided detection and diagnosis 
Once a digital image has been acquired, Computer-aided Detection and Diagnosis 
(CAD) system can be leveraged to analyze the information they hold. Over the past 
decade, dramatic increases in computational power and improvement in image analysis 
algorithms have allowed the development of powerful CAD approaches to biomedical 
image data. Just as with digital radiology over two decades ago, digitized histopathology 
has now become amenable to the application of computerized image analysis and 
machine learning techniques for an accurate diagnosis. 
For instance, a Whole Slide Images (WSI) printed at 600 dpi could fill 70 dull 
8.5" × 11" pages, to predict the cellularity of every 512 × 512 patches at a rate of 5s/patch. 
Using the CAD method, global scanning of the WSI and giving the diagnosis for each 
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patch only takes less than five minutes, but when labeling by pathologists, they may need 
12 hours or more. A WSI figure is shown in Figure 1. 
 
Figure 1. The WSI and four examples in different cancer cellularity. 
CAD as a second opinion system includes prognosis diagnosis, evaluation, and 
assessment. Different pathologists have different results in each slice. Only with 
improved consistency, will the prognostic value and outcomes be increased. So, we can 
build a CAD system to minimize this heavy work. The CAD system can pay attention to 
the slices on which pathologists have big differences in opinion from the result of CAD 
system and also give a second opinion to pathologists who have different diagnosis results. 
CAD systems reduce the workload of specialists and cost, contributing to diagnosis 
efficiency and effectiveness.  
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1.4.1 Research status 
There has already been researching about an analysis of cell and microscopy 
images in 1965, a very long time ago. Mendelsohn et al. initially demonstrated the 
morphological analysis of cells and chromosomes [10]. Over the last decade, clinical 
diagnosis and research were interested in digital pathology, a progressive technology with 
the rapid development of the Internet. Besides digital pathology, a large digital repository 
of tissue slides for medical students and pathologists is a huge educational resource. 
Using CAD tools to address specifically targeted biomarkers or segment and classify the 
cells in pathology were advanced in recent years as well. In this study, I am going to pay 
more attention to CAD field in the Artificial Neural Networks (ANN). 
Compared to traditional methods, ANN methods do not require hand-crafted 
functional design and feature extraction, however, they also can scale well to large data 
sets, and can be easily applied to other applications. ANN-based methods, especially 
those based on Convolutional Neural Networks (CNN), have received much attention in 
the field of histopathology images analysis because they have better performance in some 
applications than traditional methods. 
Wang D. et al. created a 27-layer deep network correlated with pathologists to 
identify metastatic breast cancer [11]. Han Z. et al. achieved a BiCNN model which 
combined some traditional feature descriptors, such as PFTAS and GLCM, to automated 
classify the images’ property [12]. Bayramoglu N. et al. developed a system which uses 
conditional generative adversarial networks to virtually stain the unstained 
histopathology [13]. Sari CT. et al. produced a model to extract features in 
histopathological classification field [14]. The research [13, 14] above created 
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unsupervised ANNs to analyze features automatically. Motlagh NH. et al. used a simple 
ResNet CNN model to classify binary benign-malignant assessment in breast cancer 
imaging [15].  
There are too many examples to mention. But, through the research and 
development of CNN models by many scientists in the past decades, I will research the 
breast cancer histopathology image after NAT treatment by training and generated on 
CNN model. 
1.5 Objective of this study 
Although CAD of digital pathology images has been attracting great research and 
development interest in the last decades, it still faces many technical challenges in 
automatically identifying the diseased regions, conducting cell segmentation, and 
selecting the optimal hand-craft image features to develop machine learning classifiers 
for disease diagnosis. In order to better address these challenges, researchers have 
investigated the feasibility of using deep learning approaches to develop new CAD 
schemes of digital pathology images.     
In this study, two quantitative CAD systems were utilized to automatically predict 
the cancer cellularity and classes within tumor bed in WSI breast cancer histopathology 
images of surgical or biopsy specimens acquired from the breast patients after NAT (i.e., 
neoadjuvant chemotherapies). Accurately detecting residual cancer cells and 
distinguishing (or diagnosing) cancer categories based on cancer cellularity levels is 
important for clinicians (surgeons and oncologists) to select or determine the optimal 
treatment strategy for the individual patients after NAT. The CAD systems also aim to 
minimize pathologist overloading work and give a second opinion for diagnosis. For this 
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purpose, we took the following steps in this study. First, a series of preprocessing methods 
were developed to automatically augment the size of datasets and decrease overfitting, 
which will influence the accuracy of predictions. Second, different schemes were 
compared by computing performance, and two CAD systems were used by cross-
validation to identify the optimal CNN models in solving the different problems. Third, 
different outcome layers were analyzed to fit different evaluation metrics and 
circumstances. Fourth, the CNN models were ensembled from trained processes, and 
calculated and discussed the prediction effectiveness, advantages, and disadvantages 
from the results. Finally, the potentials for further improvement were discussed to amend 
the prediction performance. 
The details of the datasets, the procedures of CAD systems and the study results 
are presented in the following sections. 
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Chapter 2: Neural networks 
2.1 ANN 
Just like 90 billion neurons form a complex neural network system in the human 
brain, the concept of neural network construction is inspired by the operation of biological 
(human or other animals) neural network [16]. Each connection, such as a synapse in a 
biological brain, can pass signals from one artificial neuron to another. Artificial neurons 
that receive the signals can process it and then signal other artificial neurons to connect 
it.  
The neural network itself is not an algorithm, but rather a framework for many 
different machine learning algorithms to work together and process complex data inputs 
[17]. Typically, artificial neurons are aggregated into layers where different layers can 
perform different types of conversions on their inputs. The output of each artificial neuron 
is calculated by activation function of the sum of its inputs. Rectified linear unit (ReLU) 
is one of the most common activation functions; it can be described as outputting the 
maximum number between 0 and x: 
𝑓(𝑥) = 𝑚𝑎𝑥⁡(0, 𝑥) 
The connection between artificial neurons is called the edge. Artificial neurons 
and edges often have weights that adjust as learning progresses. The weight increases or 
decreases the strength of the signal at the junction. The signal may propagate from the 
first layer (input layer) to the last layer (output layer) after traversing the layers multiple 
times. The commonly used ANNs in the traditional machine learning field, which used a 
limited number of subjectively defined or hand-craft image features, is shown in Figure 
2. The ANN has a 3-layer structure including an input layer with neurons represented by 
12 
 
selected image features, a hidden layer to adjust or increase discriminatory power, and an 
output layer linked with neurons represented different classes.   
Input layer
Hidden layer
Output layer
Neuron
 
Figure 2. Simplest ANN architecture. 
ANNs have been used on a variety of fields, including computer vision, natural 
language processing, image segmentation and classification, and medical diagnosis. 
Unquestionably, ANN is an ideal machine learning tool widely optimized and used in 
variety of CAD schemes of medical images including digital pathology images [18,19].  
2.2 CNN 
The challenge of developing an optimal conventional ANN is the difficulty in 
identifying a small set of effective and not redundant image features. In order to address 
and overcome this challenge, developing feature-less CNN has been attracting great 
research interest recently. A CNN is quite similar to an ANN: they are all composed of 
neurons, which have the weight and bias of learning ability. However, a CNN includes 
many input neurons and many hidden neuron layers. Each neuron gets input data and 
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performs a convolutional operation before performing an activation function. The 
network still has a loss function and a fully connection (FC) layer often performed in the 
last layers. 
The biggest difference between the CNN and the ANN is the receptive field. Each 
convolutional neuron was proposed to connect to a small sub-region of the previous layer. 
The size of the connection is called the neuron's receptive field, and its shape is square, 
and size is a hyperparameter (actually the spatial size of the filter). This architecture 
ensures the strongest response to a spatially local input pattern. The earliest CNN 
architecture is LeNet in the last decade of the last century, shown in Figure 3. 
 
(A six-layer structure: C1 + S2 + C3 + S4 + C5 + F6) 
Figure 3. Architecture of LeNet, the first successful CNN application [20]. 
The CNN has a batch filter that continuously scrolls in the picture. It only collects 
a small pixel area at each time, after collecting all the information, the output value can 
be understood as a volume, has a higher height with the size of batch filter. It will be 
inadvertently losing some information. When the volume is set, retain more information 
and the compression work is given to the max pooling layer. Such additional work can 
effectively improve accuracy. 
Pooling layer also used to reduce the spatial size and the number of parameters, 
to overcome overfitting. In addition to max pooling, average pooling was often used 
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historically but has recently fallen out of favor compared to max pooling, which performs 
better in practice [21]. 
 The following are some of the more well-known structures in the field of CNNs, 
and are sorted by accuracy from low to high which is as same as the order of years of 
birth [22]. 
 LeNet [20], the first successful CNN application was implemented by Yann 
LeCun in the 1990s. LeNet laid out three core ideas of the CNN: local receptive field, 
weight sharing, and downsampling. 
AlexNet [23] has been successfully applied to a larger variety of computer vision 
tasks. It was developed by Alex Krizhevsky et al. and won the ImageNet ILSVRC 
challenge in 2012. The network structure is very similar to LeNet, but deeper and larger. 
In terms of connection design, the number of convolutional layers is increased to 5 layers, 
the convolutional layer scales are 11x11, 5x5, 3x3, and the FC layer is increased to 3 
layers. In terms of operators, ReLU was used instead of a sigmoid as the activation 
function. Besides, Dropout and LRN were implemented to reduce overfitting and to 
normalize the data. 
ZF Net [24], the network invented by Matthew Zeiler and Rob Fergus, won the 
ILSVRC 2013 competition. It implements the improvement of AlexNet by modifying the 
hyperparameters in the structure, specifically increasing the size of the intermediate 
convolutional layer, making the step size and filter size of the first layer smaller. 
GoogLeNet [25] (Inception Net) was the winner of ILSVRC 2014. It mainly 
makes a big improvement in the convolutional layer and significantly reduces the number 
of parameters in the network (60M in AlexNet, only 4M in the GoogLeNet). While the 
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network deepens, the convolutional layer network is broadened. The influence of 
increasing the number of filters is as same as the influence of increasing the number of 
channels, and the widening network can be simply considered to be a wider structure. 
VGGNet [26] got the runner-up placement in ILSVRC 2014. Its demonstrated 
that the depth of the network is a key part of the excellent performance of the algorithm. 
Because a 5 × 5 convolution layer can be equivalent to two layers of 3 × 3 convolutions 
so that the size of convolution in VGGNet is all 3 × 3, that makes the network unit 
modularization. However, VGGNet consumes more computing resources and uses more 
parameters, resulting in more memory usage. Most of the parameters are from the first 
FC layer. It was later discovered that even if these FC layers were removed, which will 
significantly reduce the number of parameters, there will be no effect on performance. 
It is not hard to find that the performance of a CNN is improved by the deeper 
depth and wider width of networks [27]. The deeper depth means more layers in the CNN 
architecture, and the wider width means more channels in a single layer. However, deep 
networks often have gradient explosions that require very good initialization of 
parameters; deep networks also can overfit and increase the test loss. The emergence of 
Batch Normalization [28] can normalize the output of each layer so that the gradient can 
remain stable after being transmitted in the reverse layer without being too small or too 
large.  
Moreover, as the depth of the network increases, the accuracy becomes saturated 
and then decreases rapidly. This degradation is not caused by overfitting nor by gradient 
explosions, but because the network is so complicated that it is difficult to achieve the 
ideal error rate by unconstrained stocking training, which means adding more layers to 
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the appropriate depth model leads to higher training errors [27,29]. The currently widely 
used optimization methods, whether SGD [30, 31], Adam[32], or RMSProp [33], are 
unable to achieve theoretically optimal convergence results as the network depth 
increases. 
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Chapter 3: Image datasets 
This study used a publicly available image dataset, which was collected and 
ensembled from the Sunnybrook Health Sciences Centre, Toronto, Canada. It contains 
3698 patch images with a size of 512 × 512 pixels. These patch images were acquired 
from 96 WSIs, which have been stained with H&E, a commonly used stain in pathology 
for prominent cells and connective tissue. After NAT therapy, 96 WSIs were extracted 
from excised specimens of 64 patients with residual invasive breast cancer. WSIs were 
prepared and scanned using a whole slice digitizer of pathology images at 20× 
magnification (0.5µm/pixel). The two pathologists have more than 10 years of practical 
experience in reading and diagnosis of histopathology images of breast lesion specimens 
at the University of Toronto. They were involved in interpreting these images to build 
“ground-truth” in detecting residual cancer cells and scoring image slices based on their 
subjectively graded cellularity values [34]. The Canadian Cancer Society provided 
research funding to support assembling this image dataset. This dataset was made 
publicly available for research purposes and was used as a common dataset in a 
competition to develop CAD systems of histopathology images of breast lesion 
specimens namely, the SPIE-AAPM-NCI BreastPathQ: Cancer cellularity challenge in 
SPIE 2019 [35]. Figure 4 shows a number of randomly selected samples of image slices 
from the dataset. 
3.1 The training set and validation set 
The whole dataset was divided into three independent subsets. The training set 
has 2579 patches in 63 WSIs. The validation set has 185 patches in 6 WSIs. In the both 
sets, the truth ground was labeled by a single pathologist. The label is called cancer 
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cellularity, it is defined in Chapter 1 as the percentage area of the overall tumor bed that 
is comprised of tumor cells (invasive or in situ). Plus, the number is a percentile decimal 
number between 0.00 and 1.00, where 0 corresponds to 0% cellularity, and 1 corresponds 
to 100% cellularity. 
        (a)      (b)       (c)       (d) 
 
        (e)      (f)       (g)       (h) 
 
(a-b) Cellularity Scores are 0; (c) Cellularity Score is 0.1; (d) Cellularity Score is 0.35; 
(e) Cellularity Score is 0.65; (f) Cellularity Score is 0.9; (g-h) Cellularity Scores are 1.0. 
Figure 4. Samples of cancer cellularity values. 
Table 1 and Figure 5 illustrate the statistics of truth ground in the training set and 
validation set. As we can see in Table 1, the distribution of cellularity value is relatively 
uniform.  In Figure 3, it is clear that the labels from 0 to 0.1 and 0.9 to 1.0 are stepped by 
0.01 approximately; the labels between 0.1 and 0.9 are stepped by 0.05.  
Table 1. Cancer cellularity value and distribution in classes. 
 
Cancer cellularity value and distribution in classes 
 
0% 1 – 30% 31 – 70% >70% 
Training  
(Pathologist A) 
670 (28.0%) 775 (32.4%) 597 (24.9%) 352 (14.7%) 
Validation 
(Pathologist A) 
31 (16.8%) 65 (35.1%) 68 (36.8%) 21 (11.4%) 
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Figure 5. Percentage of cellularity value in the training set and validation set. 
3.2 The testing set 
The testing set has been prepared and scanned in an identical manner as the 
training set, which includes 1119 patches in 27 WSIs acquired from 18 patients. In the 
testing set, the truth ground was labeled by two pathologists and one of the pathologists 
is the same person as the pathologist who marked the training set. This testing dataset is 
used to objectively evaluate performance of CAD schemes developed by different 
research groups in the SPIE competition. Thus, the truth ground is invisible or not 
released to the researchers. The competition organizer will use this testing dataset to test 
the CAD schemes submitted to the competition and report the performance results to the 
researchers only. Table 2 demonstrates the statistics of the testing set labeled by two 
pathologists. 
3.3 ImageNet 
Since a deep CNN typically involves a huge number of weights or link 
coefficients, it needs to be trained using a very big dataset to yield or maintain high 
robustness (avoiding overfitting). The number of images in this histopathology dataset is 
too small to fully train a complete CNN. Thus, a transfer learning method was applied 
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and used in this study and the initial epoch of the CNN was pretrained by a published 
large dataset named as an ImageNet [36]. ImageNet is an image dataset organized 
according to the WordNet hierarchy [37] and consists 1000 classes. Images of each 
concept are quality-controlled and human-annotated. The models were trained on 1.28 
million training images, evaluated on 50k validation images, and tested on 100k testing 
images. 
Table 2. Cancer cellularity value and distribution in classes. 
 
0% 1 – 30% 31 – 70% >70% 
Test (Pathologist A) 242 (21.6%) 225 (20.1%) 301 (26.9%) 353 (31.4%) 
Test (Pathologist B) 237 (21.1%) 312 (27.8%) 375 (33.5%) 197 (17.6%) 
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Chapter 4: ResNet and SE-ResNeXt  
In order to apply proper CNN architectures or models, based on the literature 
review above and knowledge learned, ResNet and SE-ResNeXt were selected as the CNN 
structures applying to develop the new CAD schemes of digital histopathology images. 
Those two structures have performed very well in the field of image processing for the 
past five years. To detect residual breast cancer cells and classify cancer severity based 
on the cancer cellularity values in this study, the selected structures have relatively 
different complexity, which can be compared to the performance when the database is 
not big enough. 
4.1 Training a ResNet based CNN model  
ResNet (Residual Neural Network) [38] was proposed by Kaiming He et al. from 
the Microsoft Research Institute. ResNet was successfully trained and won the 
championship in all five main tracks of ILSVRC & COCO 2015 competitions (ImageNet: 
classification, detection, localization, and COCO: detection and segmentation). At the 
same time, the parameter quantity of ResNet is lower than VGGNet, the runner-up CNN 
scheme. The structure of ResNet can accelerate the training of neural networks very 
quickly while the accuracy of the model is also greatly improved. Also, ResNet consists 
of some similar blocks of the convolutional layer, which has strong expandability. It can 
be applied not only to previous networks but also to the subsequent networks. A simple 
block of ResNet-50 is shown in Figure 6. 
ResNet mainly solves the degradation in a deeper network. The main idea of 
ResNet is to add a direct connection channel (shortcut) to the network. The previous 
network structure was a non-linear transformation of the performance inputs, while the 
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Residual network allowed a certain percentage of the output of the previous network layer 
to be preserved and passed directly to the later layers. ResNet solved this problem to a 
certain extent. By directly transferring the input information to the output and protecting 
the integrity of the information, the entire network only needs to learn the part of the input 
and output differences, simplifying the learning objectives and difficulty.  
 
Figure 6. The block of ResNet-50. 
With the most basic ResNet block, and through stacking, different layers of the 
ResNet scheme can be generated. The ResNet-50 simple blocks contain three 
convolutional layers, as shown in Figure 6 and Table 3. The two shortcuts between the 
three blocks in conv2 stage are directly added to the output of the convolutional network. 
Meanwhile, between two different stages, ResNet connected the convolutional network 
and shortcut by using a 1 × 1 convolution kernel. The whole architecture of ResNet-50 
including the number of parameters and Floating-point Operations Per Second (FLOPs) 
is shown in Table 3. 
The last layer of ResNet is composed of the global average pool [39], FC layer 
and softmax. The global average pool is mainly used to solve the problem of full 
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connection. The main purpose is to make the feature map of the last layer into a mean 
value pool of the whole graph to form a feature point and form these feature points into 
the final feature vector. The global average uses a simple average to establish the 
connection between the feature map and the category which is a very effective way to 
reduce overfitting. For instance, in ResNet-50, the output is operated from 7 × 7 × 2048 
to 1 × 2048 by the global average pool. 
When training on the classification of an ImageNet dataset that has 1000 classes, 
the output after the global average pool is a 2048-dimension vector. FC layer acts as a 
"classifier" throughout the ResNet, mapping the learned "distributed feature 
representation" to the role of the sample marker space which is 1000 classes in ImageNet. 
In practical applications, the FC layer can be implemented by convolution operations.  
Softmax is used in the multi-classification process to map the output of multiple 
neurons to the (0,1) interval, the output with the highest probability (the value 
corresponds to the largest) or the probabilities of classes can be the final output result. 
The equation of Softmax is shown below. 
𝑆𝑖 =
𝑒𝑖
∑ 𝑒𝑗𝑗
 
In ResNet-50, the error rate of the largest softmax, called top-1 error, is 20.74% 
and the error rate of the largest five softmax, called top-5 error, is 5.25%. ResNet is the 
state-of-art CNN scheme in 2016. 
 
 
 
 
24 
 
Table 3. The architectures of ResNet-50 and ResNeXt-50 when training on 
ImageNet dataset. 
stage output ResNet-50 ResNeXt-50 (32×4d) 
conv1 112×112 7 × 7, 64, stride 2 
conv2 56×56 
3 × 3 max pool, stride 2 










256 1,×1
64 3,×3
64 1,×1
 × 3 










=
256 1,×1
32  C 128， 3,×3
128 1,×1
 × 3 
conv3 28×28 










512 1,×1
128 3,×3
128 1,×1
 × 4 










=
512 1,×1
32  C 256， 3,×3
256 1,×1
 × 4 
conv4 14×14 










1024 1,×1
256 3,×3
256 1,×1
 × 6 










=
1024 1,×1
32  C 512， 3,×3
512 1,×1
 × 6 
conv5 7×7 










2048 1,×1
512 3,×3
512 1,×1
 × 3 










=
2048 1,×1
32  C 1024， 3,×3
1024 1,×1
 × 3 
 1×1 
global average pool  
1000-d fc, softmax  
global average pool 
1000-d fc, softmax 
# params. 25.5 × 106 25.0 × 106 
FLOPs 4.1 × 109 4.2 × 109 
 
4.2 ResNeXt 
ResNeXt [40] proposes a strategy between common convolution and depth 
separable convolution: packet convolution, which balances the two strategies by 
controlling the number of packets (cardinality). The idea of packet convolution comes 
from Inception network [41]. Unlike Inception, which needs to manually design each 
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branch, the topologies of branches of ResNeXt are same. Finally, after cardinality 
architecture, ResNeXt also combined the shortcut connection and residual network. 
The simple block in ResNeXt-50 (30×4d) has 32 cardinalities, the size of the set 
of transformations. The numbers in each rectangle of Figure 7 represent numbers of 
channels, filter size, and numbers of out channels, it roughly has the same complexity of 
block in Figure 6. 
 
Figure 7. A simple aggregated residual transformation block. 
The architectures of two blocks illustrated in Figure 7 and Figure 8 are similar. In 
Figure 7, thirty-two paths of convolutional blocks were concatenated initially, and then 
the shortcut of input was concatenated as well, the paths here are all the same topology. 
On the contrary, Figure 8 is combining the idea of group convolution proposed in AlexNet 
[23]; the width is grouped and convoluted in the same layer, the input and output channels 
of 32 groups are all 4. This algorithm can reduce the amount of calculations by combining 
only after convolution in one convolution layer. In the ResNeXt paper [40], through 
experiments, the author proves that the two architectures are completely equivalent, and 
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the results of the two structures are exactly the same. However, using the Figure 8 model 
can speed up the training and be more concise, so ResNeXt uses the architecture of Figure 
8 as the block. 
 
Figure 8. The block of ResNeXt-50. Implemented as grouped convolutions [23]. 
Experiments demonstrate that increasing cardinality is a more effective way of 
gaining accuracy than going deeper or wider, especially when depth and width start to 
give diminishing returns for existing models. In particular, a 101-layer ResNeXt is able 
to achieve better accuracy than ResNet-200 [42] but has only 50% complexity. The 
detailed comparisons between ResNet-50 and ResNeXt-50 are shown in Table 3.  
4.3 Training a SE-ResNeXt based CNN model 
SENet [43], the winner of the last ImageNet competition Image Classification 
mission in 2017 reduced top-5 error to 2.251% on the ImageNet dataset, with the original 
best score being 2.991%. 
It is obvious that there are already a lot of attempts to improve the performance 
of the network in the spatial dimension, for instance, ResNet and ResNeXt. Besides, it is 
possible that the network can be considered to improve performance from other parts, 
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such as considering the relationship between feature channels. Specifically, based on 
learning loss, enhance the weight of useful features according to the degree of importance, 
and suppress the features that are not useful for the current task. The Squeeze-and-
Excitation (SE) is a method to enhance and suppress the features. SENet is not a complete 
network structure, but a substructure that can be embedded in other classification or 
detection models to recalibrate the original features. 
Figure 9 shows the basic idea of SE. The most left cube has three parameters, H, 
W, and C, which have no relationship with the size of output and numbers of channels. C 
represents the number of features, H and W are the sizes of features. In the Squeeze stage, 
through a global pooling, feature compression is performed along the spatial dimension, 
and each two-dimensional feature is turned into a real number that has a global receptive 
field to some extent, this process does not change the feature numbers C. In the Excitation 
stage, as demonstrated in Figure 10, the r is a scaling parameter, which is 16 in the SENet 
paper [43]. The purpose is to reduce the number of channels and reduce the amount of 
calculation. After two FC layers and two activation functions, the SE architecture 
achieves the purpose of learning feature weights. 
Figure 9. A Squeeze-and-Excitation block. 
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Figure 10. The block of SE-ResNeXt-50. 
Finally, in a reweight operation, the weight of the output of the Excitation can be 
regarded as the importance of each feature channel after the feature selection, and then 
weight-by-channel weighted to the previous feature to complete the pair in the channel 
dimension. The architecture of SE-ResNeXt-50 is illustrated in Table 4.  
Table 4 shows that the SENet construct is very simple and easy to deploy without 
introducing new functions or layers. In addition, it has good characteristics in terms of 
model and computational complexity, additional model parameters only exist in two new 
FCs. So, the FLOPs which was re-implemented by SENet paper [43] between ResNet-50 
and SE-ResNeXt-50 is not differing greatly.  
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Table 4. The architectures of ResNet-50 and SE-ResNeXt-50 when training on 
ImageNet dataset. 
Stage output ResNet-50 SE-ResNeXt-50 (30×4d) 
conv1 112×112 7 × 7, 64, stride 2 
conv2 56×56 
3 × 3 max pool, stride 2 










256 1,×1
64 3,×3
64 1,×1
 × 3 












=
[16,256] fc,
256 1,×1 conv,
32  C ，128 3,×3 conv,
128 1,×1 conv,
 × 3 
conv3 28×28 










512 1,×1
128 3,×3
128 1,×1
 × 4 












=
[32,512] fc,
512 1,×1 conv,
32  C ，256 3,×3 conv,
256 1,×1 conv,
 × 4 
conv4 14×14 










1024 1,×1
256 3,×3
256 1,×1
 × 6 












=
[64,1024] fc,
1024 1,×1 conv,
32  C ，512 3,×3 conv,
512 1,×1 conv,
 × 6 
conv5 7×7 










2048 1,×1
512 3,×3
512 1,×1
 × 3 












=
[128,2048] fc,
2048 1,×1 conv,
32  C ，1024 3,×3 conv,
1024 1,×1 conv,
 × 3 
 1×1 
global average pool  
1000-d fc, softmax  
global average pool 
1000-d fc, softmax 
FLOPs 3.86 × 109 3.87 × 109 
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Chapter 5: Experimental methods 
In this study, the experiments for SPIE competition and follow-up are discussed. 
First, the experiment for SPIE competition, which is predicting the cancer cellularity 
value. Second, the follow-up experiment is predicting the classes of cancer cellularity. 
After selected two CNN structures, ResNet and SE-ResNeXt, the following experiments 
were conducted to build the final integrated models and evaluate its performance.   
5.1 Pre-processing 
5.1.1 Transfer learning 
CNN needs to train on the dataset and get useful information from the data, which 
in turn translates information into corresponding weights and bias in network. The 
weights and bias are parameters, not fixed values, that need to be iteratively optimized. 
Although using a large amount of time and hardware resources, the optimal value of these 
parameters can be found, a more effective way is to extract these weights and translate to 
our target neural networks. This process is called transfer learning [44]. 
Because of the not big enough dataset, transfer the parameters from the same 
model which was trained on other similarity big datasets to this CNN model before 
training is an effective way. And then fine-tuning the models by training and iterating on 
these parameters. In this study, pre-trained models which contain the parameters of all 
layers were used from ImageNet [37], a set of containing 1000 classes annotated daily 
images. And pathology images were used as the input of first layer of CNN models. 
5.1.2 Data augmentation 
When training a machine learning model, the goal is to get an objective function 
that contains the optimal network parameters. In CNN, if the parameter can predict the 
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result even if it performs a variety of transformations on the dataset, it will be a robust 
and optimized network. 
In addition, data augmentation can not only perform transformations on the image 
but also expand the size of the dataset to minimize the influence of overfitting. When 
training on the training set, the CNN predict and fit the results precisely and flawlessly, 
but when testing on the verification set and the testing set, it cannot get the same good 
result as training. In this circumstance, CNN was considered to have been overfitting. 
The main reason for this phenomenon is the presence of noise in the training data or the 
small scale of the training dataset. 
In specifically, the dataset and truth grounds in this study are 512 × 512 square 
images and cancer cellularity, a real number between 0 and 1. When augmenting the 
dataset, the relationship between the image and the truth ground cannot be changed. If 
random cutting and random rotation without expanding are performed, the cancer 
cellularity value in the image will be transformed without the truth ground, so that it will 
be an inconsequent augmentation. 
Implementation of data augmentation includes: random flips (horizontal, vertical 
and both), random rotation (-5 to 5 degrees, expand space area), random grayscale (10% 
probability), color jitter (saturation = 0.2, hue = 0.25), and color normalize (mean = [0.485, 
0.456, 0.406], std = [0.229, 0.224, 0.225]).  
Finally, after data augmentation transforms, convert the original image size 512 
× 512 to the input size 224 × 224 that matches the model. A comparison of example from 
the training set and its data augmentation output are shown in Figure 11. 
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(left: Original; right: After augmentation) 
Figure 11. The original data and augmentation outputs. 
5.2  Model training and validation 
In addition to the model structures, details of the convolutional layer, and model 
complexity introduced in CNN section, the specific parameters in networks, subtle 
changes of the models, and methods of ensemble models will be explained in this section. 
5.2.1 Cross-validation 
Cross-validation is a statistical analysis method used to verify the performance of 
a model. The basic idea is splitting a part of the training set as a new training set, and 
another part as a validation set. Use the new training set to train the model, and another 
set for evaluation. 
By using cross-validation method, the training set and the testing set can be 
completely isolated which is a basic rule of machine learning. Only the training set can 
be used in the training process of the model, and only the testing set can be used to 
evaluate the merits of the models after training. Moreover, since increased the training 
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times of data, the generated plurality of models can be integrated together, to eliminate 
the enormous influence of erroneous data. 
Common cross-validation methods are as follows: 
Hold-out cross-validation: It's the easiest method to handle, just randomly divide 
the dataset into two groups. But there is no crossover, just the simplest grouping. 
Leave-one-out cross-validation: Almost all samples in each epoch are used to train 
the model, so the distribution is closest to the original sample. But at the same time, when 
the numbers of the dataset are large, the calculation cost is very high. 
K-fold cross-validation: The original dataset is divided into K groups, and each 
subset dataset is separately used as a validation set, and the remaining K-1 subset datasets 
are used as a training set, so that K models obtained, which can avoid overfitting 
effectively. The final result is persuasive and reasonable. 
Finally, K-fold cross-validation method was chosen for both evaluation metrics 
but applied different K values. For predicting the cancer cellularity and meeting the 
requirements of the SPIE competition, 7-fold cross-validation and seven individual 
models were trained on the training set. For predicting the classes of cancer cellularity in 
the follow-up experiment, 5-fold cross-validation was trained and tested on the training 
set, the results of 5-fold cross-validation are the final prediction results of the validation 
set individually. 
5.2.2 Models for SPIE competition 
In the competition period, the distribution of the database is divided into three 
phases: 1. Distributing the training set and its labels; 2. Distributing the validation set and 
its labels; 3. Distributing the testing set without labels. Therefore, it is necessary to use 
34 
 
the cross-validation method to select the optimal models based on the training set in phase 
1.  
ResNet-50 and SE-ResNeXt-50 were selected from a number of schemes and 
experiments. For predicting the cancer cellularity, a linear layer was used to transfer the 
outputs from pre-trained models to a single number.  
In phase 1 of SPIE competition, 7-fold cross-validation method was implemented 
by training on 2394 pathology images. Considering the overfitting and performance of 
the models, ResNet-50 at epoch 320 and SE-ResNeXt-50 at epoch 196 were chosen; each 
CNN scheme has 7 sub-models in this phase. In phase 2, competition organizer released 
a validation set includes 185 images for allowing participants to compare and adjust the 
model in the middle of the competition, SE-ResNeXt-50 was trained on the training set 
and tested on the validation set at epoch 384 which is the optimal one in the whole training 
process. Finally, ensembled 7 sub-models of ResNet-50 at epoch 320 and SE-ResNeXt-
50 model at epoch 384 as Model A. Ensembled 7 sub-models of SE-ResNeXt-50 at epoch 
196 and SE-ResNeXt-50 model at epoch 384 as Model B. Eight sub-models of each CNN 
scheme were integrated as the submission models for testing and evaluation of 
competition. 
For both of the network models, through a large number of experiments, Adam 
[32] was implemented as the optimize function and β1 is 0.9 and β2 is 0.999 which are 
the default parameters. The learning rate is adaptable from 10-4 to 10-6, the learning rate 
changes with different epochs, models and different loss functions. And the evaluation 
metric is concordance metric. 
35 
 
5.2.3 Models for follow-up experiment 
Cancer cellularity can be used to illustrate the steps of breast cancer after NAT, 
the classes of cancer cellularity can be used to perfectly explain the steps that patients 
belong to. So that in some cases, analyze classes of cancer cellularity is more intuitive 
and useful than the cancer cellularity values.  
To predict the classes, transferred the cancer cellularity to classes is necessary, 
the labels of images were changed to four discrete names as the classes at first. Class 1 
represents no-cancer cells in tumor bed; Class 2 means low-level cancer cellularity in 
tumor bed; the pathology images in Class 3 and Class 4 are belonging to mid-level and 
high-level cancer cellularity in tumor bed respectively. Based on the four classes, the last 
layer of models should have four classes as outputs and implement a softmax layer to 
calculate the probability of each class which is suitable for loss function. 
The training set in phase 1 and the validation set in phase 2 of the SPIE 
competition were combined to enlarge the dataset of predicting the classes of cancer 
cellularity. ResNet-50 and SE-ResNeXt-50 were trained by 5-fold cross-validation, and 
the results of the testing sets of each sub-model from cross-validation were constituted 
the final prediction results.  
Those two models were evaluated by ROC. Trough average the testing results 
from cross-validation process, ResNet-50 at epoch 160 and SE-ResNeXt-50 at epoch 168 
were chosen to be the Model C and Model D which are the optimum models. The 
optimize function and learning rate is as same as Model A and Model B. 
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5.3 Evaluation metrics and loss function 
Next, for participating in SPIE competition, the Model A and Model B were 
evaluated using the default evaluation metric defined by the competition organizer and 
an independent testing dataset. Furthermore, due to the lack of truth ground of 
independent testing dataset and different objective in the follow-up experiment after SPIE 
competition, another evaluation metric which is commonly used in medical image-based 
CAD schemes was implemented. 
5.3.1 Concordance metric and Mean Square Error 
Under the subjective labeling processing, different pathologists barely have the 
same diagnosis results. Variability among clinical raters’ results makes it difficult to 
define an unbiased and calibrated reference standard. Concordance metric is a good 
evaluation metric in this circumstance so that it is the default evaluation metric chosen by 
the competition organizer. 
Specifically, the testing set in this study was labeled by two pathologists. 
Prediction Probability (Pk) is one of concordance metric. This method ranks two 
randomly chosen cases in the same order as the reference standard first, and finally 
averages all of the Pk value using the two sets: prediction set and truth ground. 
Concordance pair means Case 2 > Case 1 for both sets. Discordance pair means Case 2 > 
Case 1 for one set and Case 1 > Case 2 for another set. The formula is shown below: 
𝑃𝑘 =
𝐶 +⁡
1
2𝑇
𝐶 + 𝐷 + 𝑇
⁡ 
Where C is the number of concordant pairs, D is the number of discordant pairs, 
and T is numbers of ties in the submitted algorithm results. 
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Typically, there are two different Pk values between two sets by using a different 
set as the submitted set. Furthermore, because the Pk metric only focuses on the orders of 
results in the dataset, the same Pk value cannot be used to prove that the two sets are 
identical. 
Based on this evaluation metric, Mean Square Error (MSE) was used as the loss 
function to iterate and optimize the models. This statistical parameter is the mean of the 
sum of the squares of the corresponding point errors between the predicted results and 
the truth ground. The formula is shown below: 
𝑀𝑆𝐸 =⁡
1
𝑛
∑𝑤𝑖(𝑦𝑖 −⁡ŷ𝑖)
2
𝑛
𝑖=1
 
Where n is the size of the dataset, yi is truth ground and ŷi is predict result, wi is 
the weight of data and all of the weights are 1 in this study. 
5.3.2  Receiver Operating Characteristic and cross-entropy 
Concordance metric is an evaluation metric that can only predict the order of 
results in the dataset. To truly understand whether the predicted class of the model is 
similar to the truth ground’s class, the Receiver Operating Characteristic (ROC) curve 
method was chosen to analyze the validity and rationality of the model. 
To apply the ROC curve, the regression scheme in predicting the cancer cellularity 
values should be transferred to a classification scheme. So that the cancer cellularity value 
was divided into four classes to facilitate prediction. There are four possible outcomes 
from a binary classifier. If the outcome from a prediction is positive and as same as the 
truth ground, then it is called a true positive (TP); however, if the truth ground is negative 
then it is said to be a false positive (FP). Conversely, a true negative (TN) is when both 
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the prediction outcome and the truth ground are negative, and false negative (FN) is when 
the truth ground is positive. 
The ROC is a comparison of two operating characteristics (TPR and FPR) as its 
discrimination threshold is varied. TPR is defined as the ratio of TP and the sum of TP 
and FN. FPR is defined as 1 – TNR, TNR is the ratio of TN and the sum of TN and FP. 
We also call TPR as sensitivity and TNR as specificity. 
Unlike the regression problem, the truth ground of the classification is not a 
continuous number, but a discrete name that represents different classes. Therefore, the 
output of CNN schemes are probabilities belonging to different classes. Through the 
comparison between multi-classes probabilities and truth ground, the network can iterate 
out the optimal function. The cross-entropy function describes the distance between two 
probability distributions so that it can be used for loss functions in multi-classification 
tasks. The formula is shown below: 
𝐿𝑜𝑠𝑠 = ⁡−∑𝑦𝑙𝑜𝑔ŷ𝑖
𝑛
𝑖=1
 
Where n is the size of dataset, ŷi is the probability of prediction and yi is truth 
ground which can only be 0 or 1. Unlike the original truth ground, truth ground of 
classification problem represents whether the corresponding image belongs to a class, 
where 1 means belonging, 0 means not belonging. 
5.4 Implementation 
The integrated CNN based CAD systems were developed and tested in this study 
was implemented with Python based on PyTorch [45]. The experiments were conducted 
on an Ubuntu 16.04 LTS system with Intel (R) Xeon(R) CPU E5-1620 v4 @ 3.5 GHz 
39 
 
and two GPUs of Nvidia GeForce GTX 1080Ti with 32GB memory. The speed of 
training six models which are explained above is around one epoch per minute 
approximately. 
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Chapter 6: Experimental results 
6.1 Results of SPIE competition  
When trained ResNet-50 by 7-fold cross-validation method, Figure 12 shows the 
Pk value changes with the growth of epochs. It is clearly to see that in the whole figure, 
the Pk value does not have much fluctuations, so that chosen the biggest three Pk value at 
epoch 320, epoch 340 and epoch 308. Considering the stability of the seven folds in these 
three epochs and the performance when tested on the validation set in phase 2 of 
competition, epoch 320 was selected to become the seven sub-models of Model A. 
 
Figure 12. The Pk value of Model A by 7-fold cross-validation. 
Different from the chosen in ResNet-50, because of the complexity of SE-
ResNeXt-50 is much larger than ResNet-50. When trained SE-ResNeXt-50 by 7-fold 
cross-validation method, chosen three epochs to compare the performance: the smallest 
average MSE loss value at epoch 328, shown in Figure 13; the biggest average Pk value 
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at epoch 312, shown in Figure 14; and the first epoch when started to collect information 
which is epoch 196. 
 
Figure 13. The MSE Loss value of Model B by 7-fold cross-validation. 
Figure 14. The Pk value of Model B by 7-fold cross-validation. 
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Finally, when tested on the validation set in phase 2 of competition, epoch 196 
got the best prediction and was selected to become the seven sub-models of Model B. 
Even though it has not been trained to fit the training set very well, the early epoch 
performed better in the testing set, which shows that the complexity of SE-ResNeXt-50 
is not suitable for the small database in this study, and the data deviation will have a great 
impact. In other words, the epoch that fits better with the training set has produced 
overfitting. 
In the end, a CNN model was trained on the whole training set without cross-
validation and tested on the validation set in phase 2. The loss and Pk value of this model 
is shown in Figure 15 and Figure 16. 
 
Figure 15. The MSE loss value of SE-ResNet-50 training in the whole training set. 
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Figure 16. The Pk value of SE-ResNet-50 training in the whole training set. 
The model at epoch 384 which have the optimum result Pk value was chosen to 
make up the last sub-model in Model A and Model B. The final prediction Pk value was 
calculated by the average of results of eight sub-models in Model A and Model B. 
Pk value of Model A is 0.825 when tested on the validation set and 0.92004 when 
tested on the testing set. 
Pk value of Model B got 0.803 when tested on the validation set and 0.92345 when 
tested on the testing set. 
The testing set was labeled by two pathologists, the Pk value is 0.962 when 
pathologist B as a submitted group and pathologist A as truth ground group, in contrast, 
when pathologist A as a submitted group and pathologist B as truth ground group, the Pk 
value is 0.929. The different results are due to the characteristic of the concordance metric. 
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There are 101 total qualified algorithms from 37 participations submitted to 
competition organizer. The ranking of participation still does not be released. But Figure 
17 shows the distribution information of results in the SPIE challenge competition. 
 
Figure 17. Distribution information of results in the SPIE challenge competition. 
6.2 Results of follow-up experiment 
Different from the prediction of cancer cellularity value, when set up a CAD 
system to predict the classes of cancer cellularity, the cancer cellularity should be 
transferred to four classes first. Because of lacking the labels of the testing set, the models 
can only get the results of the validation set in the five sub-models through the 5-fold 
cross-validation method. Finally, the five results were combined to cover the entire 
training set, in this way, the labels of the training set did not affect the predicted results. 
By comparing the largest accuracy values, cross-entropy loss values and complexity of 
models, the epoch 160 of ResNet-50 as Model C and the epoch 168 of SE-ResNeXt-50 
as Model D were optimum choices for implemented to the CAD system. The accuracy of 
Model C is 66.93% and loss value is 2.18 × 10-5 , the accuracy of Model D is 73.05% and 
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loss value is 9.29 × 10-6. Related figures are shown in Figure 18 to Figure 21. Figure 22 
and Figure 23 shows the ROCs of Model C and Model D.  
 
Figure 18. The accuracy of cancer cellularity classification by Model C. 
 
Figure 19. The cross-entropy loss of cancer cellularity classification by Model C. 
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Figure 20. The accuracy of cancer cellularity classification by Model D. 
 
Figure 21. The cross-entropy loss of cancer cellularity classification by Model D. 
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Figure 22. The ROC curve of Model C when predicting the classes. 
 
Figure 23. The ROC curve of Model D when predicting the classes. 
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The evaluation index of the binary classifier, area under the ROC curve (AUC), 
can be used as an indicator to evaluate models, AUC equals to 1 is the ideal model. For 
Model C, AUC of four classes are 0.95, 0.89, 0.78 and 0.95, the average AUC value of 
four classes is 0.893 ± 0.113; For Model D, AUC of four classes are 0.93, 0.90, 0.83 and 
0.96, the average AUC value of four classes is 0.905⁡±⁡0.075. 
Table 5 and Table 6 summarized the performance of the sensitivity and specificity 
with different thresholds over the different CNN schemes. 
Table 5. Performance of Model C for cancer cellularity classification. 
 
 
Table 6. Performance of Model D for cancer cellularity classification. 
 
  
sensitivity specificity sensitivity specificity sensitivity specificity sensitivity specificity
Class 1 0.595 0.988 0.488 0.995 0.412 0.997 0.245 0.998
Class 2 0.858 0.746 0.814 0.800 0.750 0.848 0.639 0.901
Class 3 0.687 0.757 0.585 0.822 0.481 0.878 0.301 0.938
Class 4 0.820 0.937 0.751 0.956 0.694 0.971 0.539 0.986
Classes
Threshold = 0.3 Threshold = 0.5 Threshold = 0.7 Threshold = 0.9
sensitivity specificity sensitivity specificity sensitivity specificity sensitivity specificity
Class 1 0.763 0.947 0.725 0.963 0.665 0.975 0.568 0.987
Class 2 0.904 0.763 0.865 0.802 0.824 0.833 0.755 0.872
Class 3 0.528 0.894 0.444 0.923 0.386 0.945 0.257 0.967
Class 4 0.869 0.933 0.831 0.946 0.815 0.960 0.718 0.976
Classes
Threshold = 0.3 Threshold = 0.5 Threshold = 0.7 Threshold = 0.9
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Chapter 7: Discussion and conclusion 
7.1 Discussion and future works 
In this study, two CAD systems were implemented for predicting the cancer 
cellularity value and cancer cellularity classification. For each CAD system, two CNN 
schemes were compared and combined to some extent to complete the assessment and 
diagnosis of the problem requirements. In general, during the entire research process of 
model selection and model evaluation, there are several widely exist problems as follows: 
overfitting, the complexity of models and the absence of the testing dataset. 
First, whatever the system for predicting cancer cellularity value or cancer 
cellularity classification, the overfitting circumstance always exist. To overcome 
overfitting, fully use and enlarge the training set, data augmentation and cross-validation 
were used in the CAD systems. From the results and figures, the model which fitting more 
and more in the training set, the performance on the testing set is not showing better. Such 
as in Figure 13 vs. Figure 14, Figure 18 vs. Figure 19, and Figure 20 vs. Figure 21. 
Although the output values of various loss functions decreased with the increase of the 
training epochs, the results of evaluation did not increase significantly, instead of were 
stabilized near a certain value in the form of waves.  
So that select the models which are at the early epochs is better for evaluation and 
assessment. Increase the size of the training set and let the training set covers more and 
more different cases that may be happened in the assessment processing are other 
effective ways to solve overfitting. Even if obtaining the pathology images is a time 
consuming and difficult task, increasing the size of the dataset is an indispensable 
condition for future research. At the same time, in the future, it is also important to adjust 
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the structure of the deep learning network models to make it more adaptable to a small 
number of datasets. 
Second, in this study, two CNN schemes were selected to compare the differences. 
From the results, the performance of SE-ResNeXt-50 is commonly better than the 
performance of ResNet-50. The same result actually can be seen from the performances 
of ImageNet. This proves that a better model is effective for improving performance. 
However, in the field of medical image processing, because the size of the dataset is small, 
it is difficult to perform deep neural network processing. More complex network 
structures mean more loss of accuracy in evaluating diverse data. Precisely, because of 
the diversification and unpredictability of medical images data, there are a lot of 
requirements for the professional doctors. Therefore, the current CAD system can only 
exist as a second opinion in the doctor's clinical diagnosis process. 
Third, the absence of the testing dataset. Because the testing set in SPIE 
competition is used to be an objective evaluation dataset, its truth ground is invisible and 
not released to the researchers, so in the subsequent research, only the cross-validation 
can be used to aggregate the predicted values of each validation. And finally, use the 
summarized results of the verification set as an objective output for the entire training set. 
Although this is an experimental process that completely isolates the training set and the 
testing set, have not been tested in the additional datasets, making the model cannot fully 
convincing for evaluating diverse data. 
In addition to the above three points, there are still many details that can be 
improved in future research.  
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1. Instead of using sub-models at the same epoch, different epochs can be selected 
for different sub-models, which can make up for the deficiencies between the 
models and make the model performance more excellent.  
2. Applying more data augmentation methods to augment the dataset and eliminate 
the effects of overfitting is another way.   
3. Expand more truth ground information which is outside the medical images. Such 
as in the pathology image of breast cancer, the age of the patient, the number of 
days after cancer detected, and the number of days after NAT treatment. Using 
these truth grounds may have a small impact on the forecast results. 
4. Do not use cancer cellularity as the only annotation, positioning the location of 
cancer cells in pathology images, or segmenting the boundaries of cancer cells, 
will greatly improve the performance of the model. But at the same time, marking 
these truth grounds is very time consuming and inefficient. There is no medical 
value in clinical manifestations. 
Of course, researching and developing a better CNN model is a top priority and a 
key to greatly improving the performance of the CAD system. 
7.2 Conclusion 
In the past decade, with a significant increase in computing power and digitization 
in various fields, the CAD system of medical digital images has become possible. 
Applying CAD system to help doctors make a clinical diagnosis can greatly improve the 
efficiency and robustness of diagnosis, reduce the time cost, and if applied properly, it is 
possible for medical teaching, long-distance medical diagnosis, and even gradually 
independent diagnosis in the future instead of as a second opinion. For this reason, in this 
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study, four deep learning network models were used to predict and evaluate cancer 
cellularity information in breast histopathology images after NAT treatment. 
As a result of the SPIE competition, the Model B presented in this study is in the 
top 15% of all valid submissions. The Pk value of Model B is very similar to the Pk value 
between two pathologists who labeled the testing set individually. From Figure 12 and 
Figure 14, in the competition phase 1, the Pk value of Model B is greater than the Pk value 
of Model A as well. It can be said that the Model B developed based on SE-ResNeXt-50 
has better performance.  
However, in phase 2, since the validation set only contains 185 images, and the 
distribution of truth ground in the validation set is quite different from the training set, 
the Pk value of Model B is not better than Model A, because Model A has less overfitting. 
The differences in the distribution of two datasets also explain why the competition 
results are much better than the results of the validation. 
In the cancer cellularity classification, from the accuracy and cross-entropy loss 
value shown in Figure 18 to Figure 21, Model D is better than Model C; from the ROC 
curve, the Model D is larger than Model C in the AUC value of average, Class2, Class3, 
and Class4, Model C just better in predicting Class 1; from the performance table of 
sensitivity and specificity, Model D also has a better performance for predicting the 
classes of cancer cellularity. In summary, Model D has better performance. By 
developing more models to compare the performance in the future can give more 
comparisons and references for pathologists’ clinical diagnosis. 
In conclusion, this study shows that CAD systems developed by CNN schemes 
such as SE-ResNeXt and ResNet are an effective and efficient method for the diagnostic 
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of residual breast cancer cells in pathological images after NAT treatment. And let CAD 
systems to be the second opinion for pathologists is useful and valuable. 
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